Positron Emission Mammography: Correlation of Estrogen Receptor, Progesterone Receptor, and Human Epidermal Growth Factor Receptor 2 Status and18F-FDG
作者： Carolyn L. Wang , Lawrence R. MacDonald , James V. Rogers , Aleksandr Aravkin , David R. Haseley
DOI: 10.2214/AJR.11.6478
关键词:
摘要: OBJECTIVE. The study objective was to assess the correlation between 18F-FDG uptake values on positron emission mammography (PEM), expressed as maximum value and lesion-to-background ratio, receptor status (i.e., estrogen [ER], progesterone [PR], human epidermal growth factor 2 [HER2]), tumor histology, grade. We also evaluated for PEM a whole-body PET/CT. MATERIALS AND METHODS. retrospectively reviewed our database patients with newly diagnosed breast cancer who were referred June 2007 September 2009. A subset of underwent PET/CT scan. original pathology reports establish histologic type, grade, status. RESULTS. involved 98 100 lesions. ER-negative tumors PR-negative had significantly higher mean ratio than did their respective recep...
sci-hub.se 参考文章(45)
M. Funke, C. Villena, Bildgebende Diagnostik des Mammakarzinoms Radiologe. ,vol. 48, pp. 601- 614 ,(2008) , 10.1007/S00117-008-1676-Z
Lisa M. Precht, Kimberly A. Lowe, Mary Atwood, J. David Beatty, Neoadjuvant chemotherapy of breast cancer: tumor markers as predictors of pathologic response, recurrence, and survival. Breast Journal. ,vol. 16, pp. 362- 368 ,(2010) , 10.1111/J.1524-4741.2010.00935.X
Jennet M. Harvey, Gary M. Clark, C. Kent Osborne, D. Craig Allred, Estrogen Receptor Status by Immunohistochemistry Is Superior to the Ligand-Binding Assay for Predicting Response to Adjuvant Endocrine Therapy in Breast Cancer Journal of Clinical Oncology. ,vol. 17, pp. 1474- 1474 ,(1999) , 10.1200/JCO.1999.17.5.1474
Norbert Avril, Fritz Jänicke, Jörg Dose, Markus Schwaiger, Marcus Schelling, Walter Nathrath, Wolfgang Weber, Manuela Menzel, Glucose Metabolism of Breast Cancer Assessed by 18F-FDG PET: Histologic and Immunohistochemical Tissue Analysis The Journal of Nuclear Medicine. ,vol. 42, pp. 9- 16 ,(2001)
Robert Lisbona, Christopher J. Thompson, Marianne Aznar, Kavita Murthy, Antoine Loutfi, Jean H. Gagnon, Results of Preliminary Clinical Trials of the Positron Emission Mammography System PEM-I: A Dedicated Breast Imaging System Producing Glucose Metabolic Images Using FDG The Journal of Nuclear Medicine. ,vol. 41, pp. 1851- 1858 ,(2000)
Isabelle Soerjomataram, Marieke W. J. Louwman, Jacques G. Ribot, Jan A. Roukema, Jan Willem W. Coebergh, An overview of prognostic factors for long-term survivors of breast cancer Breast Cancer Research and Treatment. ,vol. 107, pp. 309- 330 ,(2008) , 10.1007/S10549-007-9556-1
Lawrence R. MacDonald, Carolyn L. Wang, Marna Eissa, David Haseley, Mary M. Kelly, Franklin Liu, Jay R. Parikh, J. David Beatty, James V. Rogers, Positron emission mammography (PEM): Effect of activity concentration, object size, and object contrast on phantom lesion detection Medical Physics. ,vol. 39, pp. 6499- 6508 ,(2012) , 10.1118/1.4754651
Sandip Basu, Wengen Chen, Julia Tchou, Ayse Mavi, Tevfik Cermik, Brian Czerniecki, Mitchell Schnall, Abass Alavi, Comparison of triple-negative and estrogen receptor-positive/progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron emission tomography imaging parameters: a potentially useful method for disease characterization. Cancer. ,vol. 112, pp. 995- 1000 ,(2008) , 10.1002/CNCR.23226
C. J. Thompson, K. Murthy, I. N. Weinberg, F. Mako, Feasibility study for positron emission mammography Medical Physics. ,vol. 21, pp. 529- 538 ,(1994) , 10.1118/1.597169
Andreas Buck, Holger Schirrmeister, Thorsten Kühn, Changxian Shen, Thomas Kalker, Jörg Kotzerke, Anja Dankerl, Gerhard Glatting, Sven Reske, Torsten Mattfeldt, FDG uptake in breast cancer: correlation with biological and clinical prognostic parameters. European Journal of Nuclear Medicine and Molecular Imaging. ,vol. 29, pp. 1317- 1323 ,(2002) , 10.1007/S00259-002-0880-8